- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
TRMED
OSL
Week ended 07 Aug 2026
Weekly Investor Report
Thor Medical ASA · Healthcare · Biotechnology
Latest close
5.43 NOK
-8.0%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 16.8% above the Trend Line and sits at 83.7% of its 52-week range. The latest completed week returned -8.0%, after a 29.6% four-week move. The latest news-sentiment score is 50/100.
Setup score
65
out of 100
Latest Close
5.43 NOK
7 Aug 2026
1W Return
-8.0%
latest completed week
4W Return
29.6%
short-term follow-through
12W Return
22.6%
quarterly tape
Trend Breadth
75.0%
39 of 52 weeks active
Volume Ratio
6.0x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is weak, so confirmation is not yet broad enough.
- 2 reversal markers appear in the recent smart-money tape.
- The latest week was a sharp negative move.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-8.0%
Latest completed week; four-week move 29.6%.
Indicator stack
41/63
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
8 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 16.8% above the Trend Line and sits at 83.7% of its 52-week range. The latest completed week returned -8.0%, after a 29.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 6.0x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.2812-week average 0.31
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure1/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership3/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.28Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 29.6% over four weeks, 22.6% over 12 weeks, and 128.2% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year39
Trend breadth75.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.22Latest activity-pressure read.
Pressure change120.0%Four-week change in activity pressure.
Leadership12.24Latest relative-leadership reading.
RS change295.8%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 8 relevant articles.
1 positive · 7 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-10.0%Distance below the 52-week high.
13-week volatility10.0%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher14 of 2612 weeks finished lower.
Best week+32.9%Week of 31 Jul.
Worst week-14.4%Week of 20 Feb.
Latest week-8.0%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains8
Flat weeks0
Modest losses6
Sharp losses6
Recent vol10.0%13-week weekly-return volatility.
Base vol8.6%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew6.9% / -5.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorNO Healthcare
4-week rank1 / 24
Group average4.3%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD37.5%positive activity pressure
RS29.2%positive relative leadership
Four-week leaders
IndustryNO Biotechnology
4-week rank1 / 11
Group average9.2%
Trend breadth36.4%
Trend36.4%active weekly trend signals
MD27.3%positive activity pressure
RS45.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape59/100
Trend, activity pressure, participation, and risk combine to a 59/100 tape read.
Indicator analysis16/100Latest 12-week confirmation: trend 0/12, activity pressure 1/12, relative leadership 3/12.
Activity pressure 0.28; 2 reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 8 relevant articles.
Thor Medical ASA: First Customer Delivery Completed from AlphaOne Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 5.43 NOK | -8.0% | 4.65 NOK | 2.57 NOK | 0.22 | 12.24 | 43.2M | Off |
| 31 Jul 2026 | 5.90 NOK | 32.9% | 4.64 NOK | 2.55 NOK | -0.46 | 23.64 | 22.7M | Off |
| 24 Jul 2026 | 4.44 NOK | 3.6% | 4.61 NOK | 2.52 NOK | -0.99 | -5.41 | 3.4M | Off |
| 17 Jul 2026 | 4.29 NOK | 2.3% | 4.64 NOK | 2.50 NOK | -1.06 | -5.85 | 2.3M | Off |
| 10 Jul 2026 | 4.19 NOK | -5.7% | 4.64 NOK | 2.49 NOK | -1.08 | -6.25 | 2.0M | Off |
| 3 Jul 2026 | 4.45 NOK | 4.6% | 4.64 NOK | 2.47 NOK | -1.04 | -0.60 | 1.2M | Off |
| 26 Jun 2026 | 4.25 NOK | 1.3% | 4.63 NOK | 2.45 NOK | -1.11 | -2.18 | 775.4K | Off |
| 19 Jun 2026 | 4.20 NOK | 0.2% | 4.64 NOK | 2.44 NOK | -0.98 | -5.38 | 895.6K | Off |
| 12 Jun 2026 | 4.18 NOK | 1.2% | 4.62 NOK | 2.42 NOK | -0.95 | -7.26 | 909.6K | Off |
| 5 Jun 2026 | 4.13 NOK | -10.9% | 4.61 NOK | 2.41 NOK | -0.97 | -8.40 | 1.5M | Off |
| 29 May 2026 | 4.64 NOK | 2.5% | 4.59 NOK | 2.40 NOK | -0.99 | 3.38 | 5.0M | Off |
| 22 May 2026 | 4.53 NOK | 2.1% | 4.55 NOK | 2.38 NOK | -1.05 | -0.63 | 5.4M | Off |
| 15 May 2026 | 4.43 NOK | 0.5% | 4.52 NOK | 2.35 NOK | -0.95 | -0.91 | 3.6M | Off |
| 8 May 2026 | 4.41 NOK | -0.3% | 4.49 NOK | 2.33 NOK | -0.68 | 1.49 | 7.2M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.